Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Stockholders of record on Friday, March 21st will be given a dividend of 0.48 per share on Thursday, May 1st. The ex-dividend date of this dividend is Friday, March 21st. This is a 2.1% increase from Hikma Pharmaceuticals’s previous dividend of $0.47.
Hikma Pharmaceuticals Stock Up 1.5 %
OTCMKTS:HKMPF opened at $26.20 on Wednesday. The company has a 50-day moving average price of $26.71 and a 200-day moving average price of $25.45. Hikma Pharmaceuticals has a 12 month low of $22.33 and a 12 month high of $28.92. The company has a quick ratio of 0.98, a current ratio of 1.66 and a debt-to-equity ratio of 0.46.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada raised shares of Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a research report on Tuesday, December 10th.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Stocks Returning Billions to Shareholders via Buybacks
- P/E Ratio Calculation: How to Assess Stocks
- Tesla: 1 Reason to Love It, 1 Reason to Be Cautious
- 3 Stocks to Consider Buying in October
- 3 Stocks That Could Win Big From a 10% Cap on Credit Card Rates
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
